Exploring Natural Products with Antioxidant and Anticancer Properties, 2nd Edition
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 25 March 2026 | Viewed by 607
Special Issue Editors
Interests: ethnobotany; ethnopharmacology; anticancer; organoid models; anti-inflammatory
Special Issues, Collections and Topics in MDPI journals
Interests: antioxidants; cytotoxicity; antitumor action; cancer; the prospection of bioactive molecules of natural and synthetic origin
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer remains the second leading cause of mortality globally. It is estimated that by 2030, cancer will lead to almost 13 million deaths worldwide. Moreover, cancer therapies are constrained by the emergence of drug resistance and other associated challenges. Undoubtedly, there is a need for new drugs that are combined with natural compounds for better outcomes. Since oxidation has been implicated in the progression and development of cancer, antioxidants have been suggested as one of the viable solutions in its treatment. This is because antioxidants play significant roles in the preservation of cellular integrity and, therefore, in sustaining the homeostasis of the host immune system.
In this Special Issue, we welcome submissions of well-designed studies, relying on scientific methods and statistical analysis, that explore natural products—be it from plants, fungus, animals or other sources—which exhibit anticancer and antioxidant properties.
Dr. Sikiru Olaitan Balogun
Dr. Edson Lucas Dos Santos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antioxidant
- anticancer
- neoplasms
- natural products
- cytotoxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
